Richard Marzouka
Contributor since: 2017
Update On Mirati Therapeutics (MRTX)
Up And Down We Go Until A Floor Is Found
Waiting For Better Entry To Buy China ETFs
Weak Outlook For Gold Investing
Micron Will Grind Higher
Micron Technical Outlook
Reviewing And Changing Previous Recommendations
Market Weakness DJI, SPX, And MU
Portola Pharmaceutical: Buyout Candidate
Financials Stumble
Taking Profit On G1 Therapeutics
Micron Breakout Or Fake Out
Buying Aerospace During Market Uncertainty
Offset Volatility With Exposure To Aerospace And Defense
Taking Profit From KALA Pharmaceuticals
Micron Technology: Buying This Dip
Bitcoin Investment Trust Big Reset
Loxo Oncology An Opportunity
A Lesson On Volatile Biotech Trading
Veritone A Tech Play Put On Hold
Biotech Stocks Expected To Go Higher After ESMO
Array Biopharma A Good Entry Point Ahead Of ESMO
Positive News Expected From Clovis Oncology
Adamas Pharmaceuticals ADS-5102 PDUFA
Trading Biotech ARNA, SRPT
Good Entry Point On LABU, MRTX
ABEO, BGNE Are Buying Opportunities!
Pfizer And PDUFA Reviews
Semiconductors And Data Analytics MU, VERI
Small Biotech GTHX
Sangamo Therapeutics A Good Entry Point
Biotech Trades Buy MYOK, Sell SAGE